Suppr超能文献

人血红素加氧酶-1逆转录病毒基因转移对肺微血管内皮细胞中环磷酸鸟苷的调节作用。

Modulation of cGMP by human HO-1 retrovirus gene transfer in pulmonary microvessel endothelial cells.

作者信息

Abraham Nader G, Quan Shuo, Mieyal Paul A, Yang Liming, Burke-Wolin Theresa, Mingone Christopher J, Goodman Alvin I, Nasjletti Alberto, Wolin Michael S

机构信息

Department of Pharmacology, New York Medical College, Valhalla, New York 10595, USA.

出版信息

Am J Physiol Lung Cell Mol Physiol. 2002 Nov;283(5):L1117-24. doi: 10.1152/ajplung.00365.2001.

Abstract

Carbon monoxide (CO) stimulates guanylate cyclase (GC) and increases guanosine 3',5'-cyclic monophosphate (cGMP) levels. We transfected rat-lung pulmonary endothelial cells with a retrovirus-mediated human heme oxygenase (hHO)-1 gene. Pulmonary cells that expressed hHO-1 exhibited a fourfold increase in HO activity associated with decreases in the steady-state levels of heme and cGMP without changes in soluble GC (sGC) and endothelial nitric oxide synthase (NOS) proteins or basal nitrite production. Heme elicited significant increases in CO production and intracellular cGMP levels in both pulmonary endothelial and pulmonary hHO-1-expressing cells. N(omega)-nitro-L-arginine methyl ester (L-NAME), an inhibitor of NOS, significantly decreased cGMP levels in heme-treated pulmonary endothelial cells but not heme-treated hHO-1-expressing cells. In the presence of exogenous heme, CO and cGMP levels in hHO-1-expressing cells exceeded the corresponding levels in pulmonary endothelial cells. Acute exposure of endothelial cells to SnCl2, which is an inducer of HO-1, increased cGMP levels, whereas chronic exposure decreased heme and cGMP levels. These results indicate that prolonged overexpression of HO-1 ultimately decreases sGC activity by limiting the availability of cellular heme. Heme activates sGC and enhances cGMP levels via a mechanism that is largely insensitive to NOS inhibition.

摘要

一氧化碳(CO)刺激鸟苷酸环化酶(GC)并提高鸟苷 3',5'-环磷酸(cGMP)水平。我们用逆转录病毒介导的人血红素加氧酶(hHO)-1 基因转染大鼠肺内皮细胞。表达 hHO-1 的肺细胞 HO 活性增加了四倍,同时血红素和 cGMP 的稳态水平降低,而可溶性 GC(sGC)和内皮型一氧化氮合酶(NOS)蛋白或基础亚硝酸盐生成没有变化。血红素在肺内皮细胞和表达 hHO-1 的肺细胞中均引起 CO 生成和细胞内 cGMP 水平的显著增加。NOS 抑制剂 N(ω)-硝基-L-精氨酸甲酯(L-NAME)显著降低血红素处理的肺内皮细胞中的 cGMP 水平,但对血红素处理的表达 hHO-1 的细胞没有影响。在存在外源性血红素的情况下,表达 hHO-1 的细胞中的 CO 和 cGMP 水平超过肺内皮细胞中的相应水平。内皮细胞急性暴露于 HO-1 诱导剂 SnCl2 会增加 cGMP 水平,而慢性暴露则会降低血红素和 cGMP 水平。这些结果表明,HO-1 的长期过表达最终通过限制细胞血红素的可用性来降低 sGC 活性。血红素通过一种对 NOS 抑制 largely 不敏感的机制激活 sGC 并提高 cGMP 水平。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验